The Nordic-American Healthcare Conference
The leading US-Nordic healthcare equity conference in the US with a sole focus on
US-Nordic collaboration and healthcare growth.
Now celebrating its tenth year, the NAHC continues to unite innovative life science companies with exceptional technologies or advances from across the Nordic region and North America with investors, industry leaders and entrepreneurs for two days of strategic dialogue, company presentations and networking.
This milestone year will feature expanded programming and expert-led panels exploring emerging trends and opportunities in healthcare innovation.
Join us to connect with global leaders and be a part of shaping the next decade of healthcare advancement.
NAHC 2025 BY THE NUMBERS:
250 attendees
85+ registered US healthcare investors. See examples of our registered investors.
40 high-caliber investment firms - Black Rock, OMERS, Lord Abbett, Invesco, etc.
Institutional investors/funds, PE, VC, family offices
25 large and mid-cap presenting companies
20 stock-listed, five privately owned
>$420B total market cap represented
$20B average market cap for all presenting companies
80% of companies presented by C-Suite
More than 240 individual meeting requests facilitated on behalf of investors
4 tracks: rare disease, biopharma, oncology, and medtech advances
2 keynote remarks delivered by Dr. Rachel L. Levine, 17th US Assistant Secretary for Health, and Mary Anne Heino, Chairperson of the Board for Lantheus
NAHC 2025 presenting companies:
